Changchun GeneScience Pharmaceutical Co., Ltd.

🇨🇳China

Country: 🇨🇳China

Ownership: -

Established: 1948-01-01

Employees: -

Market Cap: -

Website: http://english.ciac.cas.cn/

Clinical Trials

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency

Phase 4

Conditions: Growth Hormone Deficiency

Interventions: Biological: PEG-somatropin

First Posted Date: 2016-11-29

Last Posted Date: 2017-06-16

Lead Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

Target Recruit Count: 600

Registration Number: NCT02976675

Locations: 🇨🇳
Maternal and Child Health Hospital of Guiyang City, Guiyangtou, Guizhou, China
🇨🇳
Hebei Provincial People's Hospital, Shijiazhuang, Hebei, China
🇨🇳
Maternal and Child Health Hospital of Anhui province, Hefei, Anhui, China

and more 21 locations

Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency

Phase 4

Conditions: Growth Hormone Deficiency

Interventions: Biological: PEG-somatropin

First Posted Date: 2016-09-21

Last Posted Date: 2017-06-14

Lead Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

Target Recruit Count: 900

Registration Number: NCT02908958

Locations: 🇨🇳
The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
🇨🇳
Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China
🇨🇳
Qilu Children's Hospital of Shandong University, Jinan, Shandong, China

and more 19 locations

Effect of Recombinant Human Growth Hormone Injection on the Clinical Outcome of POR in Patients Undergoing IVF/ET

Conditions: Poor Ovarian Response

Interventions: Procedure: Conventional ovarian stimulation proctol without rhGH

First Posted Date: 2016-06-16

Last Posted Date: 2016-06-16

Lead Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

Target Recruit Count: 240

Registration Number: NCT02801591

Locations: 🇨🇳
Peking University Third Hospital, Beijing, China
🇨🇳
People's Hospital of Peking University, Beijing, China

Clinical Observation of Recombinant Human Growth Hormone Injection Assisted IVF-ET in the Treatment of PCOS

Not Applicable

Conditions: Polycystic Ovary Syndrome

Interventions: Drug: Conventional controlled ovarian stimulation proctol

First Posted Date: 2016-06-16

Last Posted Date: 2016-11-28

Lead Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

Target Recruit Count: 208

Registration Number: NCT02801565

Locations: 🇨🇳
Peking University Third Hospital, Beijing, China

Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)

Phase 4

Conditions: Growth Hormone Deficiency

Interventions: Biological: PEG-somatropin

First Posted Date: 2015-03-05

Last Posted Date: 2017-06-16

Lead Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

Target Recruit Count: 600

Registration Number: NCT02380235

Locations: 🇨🇳
Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing, Beijing, China
🇨🇳
Chinese Academy of Medical Sciences &Peking Union Medical College, Beijing, Beijing, China
🇨🇳
Children's Hospital of Fudan University, Shanghai, Shanghai, China

and more 9 locations

Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature

Phase 2

Conditions: Small for Gestational Age Infant

Interventions: Biological: PEG-somatropin

First Posted Date: 2015-03-02

Last Posted Date: 2015-03-02

Lead Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

Target Recruit Count: 96

Registration Number: NCT02375620

Locations: 🇨🇳
Hunan Children's Hospital, Changsha, Hunan, China
🇨🇳
Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China
🇨🇳
First Hospital of Jilin University, Changchun, Jilin, China

and more 4 locations

Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation

Phase 3

Completed

Conditions: Anovulation

Interventions: Biological: Gonal-F

First Posted Date: 2015-01-12

Last Posted Date: 2015-01-12

Lead Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

Target Recruit Count: 534

Registration Number: NCT02335879

Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children

Phase 4

Conditions: Dwarfism, Pituitary

Interventions: Biological: PEG-somatropin

First Posted Date: 2014-12-11

Last Posted Date: 2014-12-11

Lead Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

Target Recruit Count: 900

Registration Number: NCT02314676

Locations: 🇨🇳
First People's Hospital of Wuhu, Wuhu, Anhui, China
🇨🇳
Children's Hospital Affiliated to Zhejiang University, Hangzhou, Zhejiang, China

Efficacy and Safety Study of rhGM-CSF Gel to Treat Deep 2nd Thickness Burn

Phase 4

Completed

Conditions: Deep Partial Thickness Burn

Interventions: Drug: rhGM-CSF Gel

First Posted Date: 2013-02-07

Last Posted Date: 2013-02-07

Lead Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

Target Recruit Count: 2510

Registration Number: NCT01785784

Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children

Phase 1

Completed

Conditions: Growth Hormone Deficiency

First Posted Date: 2012-06-07

Last Posted Date: 2012-06-14

Lead Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

Target Recruit Count: 12

Registration Number: NCT01613573

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy